An explanation of the pathophysiology of adverse neurodevelopmental outcomes in iron deficiency

Area of Science:

• Pediatrics
• Neuroscience
• Public Health

Background:

• Iron deficiency (ID) is a significant global health concern in infants aged 0-12 months.
• Contributing factors include inadequate iron supplementation, exclusive breastfeeding, and early umbilical cord clamping.
• Beyond anemia, ID poses risks to long-term neurodevelopment.

Purpose of the Study:

• To review the mechanisms by which iron deficiency impacts infant neurodevelopment.
• To summarize the long-term consequences of infant ID on cognitive and motor functions.
• To propose recommendations for future clinical research in infant iron status.

Main Methods:

• Literature review of clinical studies on iron deficiency in infants.
• Analysis of research on neurodevelopmental outcomes associated with infant ID.
• Synthesis of findings on the underlying biological mechanisms of ID-induced neurotoxicity.

Main Results:

• Infant ID anemia negatively affects fetal and neonatal behavior, including motor maturity, autonomic response, memory, learning, and mood.
• ID-induced neurodevelopmental deficits can persist into later life, even after iron repletion.
• Key mechanisms involve impaired myelination, altered neurotransmission, and disrupted synaptogenesis/dendritogenesis.

Conclusions:

• Iron deficiency in infancy has profound and potentially permanent effects on neurodevelopment.
• Understanding the molecular and cellular mechanisms is vital for developing effective interventions.
• Further research is needed to optimize strategies for preventing and treating infant iron deficiency and its neurodevelopmental sequelae.